Investors betting on short-term gains will miss out when Powell ‘wins the game,’ Cramer says

Investors betting on short-term gains will miss out when Powell ‘wins the game,’ Cramer says


Investors betting on short-term gains will miss out when Powell 'wins the game,' Cramer says

CNBC’s Jim Cramer on Wednesday advised investors to think of the bigger picture when it comes to the Federal Reserve’s battle against inflation and its effect on the stock market.

“The short-term camp is made up of people who either can’t handle any pain or don’t believe in [Fed Chair Jerome] Powell and want to get out,” the “Mad Money” host said.

“I think Powell wins the game and when he does, we’ll be on the field and the short-termers will be at the bottom of the stands,” he added.

The Fed raised interest rates by 75 basis points on Wednesday and signaled that it will continue its aggressive campaign against inflation.

Stocks ended the volatile trading session down as Wall Street digested the news.

Cramer acknowledged that there will be pain ahead for the market, and advised investors to bet with the Fed if they want their portfolios to stay intact in the long term. 

People who believe in Powell’s vision — whom Cramer calls the silent majority — understand the central bank has to increase interest rates to avoid pain even further down the line, he said.

“The silent majority wants to be able to buy a house at a reasonable price without having a bidding war over it,” he said. “The silent majority knows that their stocks are going to be worth less when they retire if Powell doesn’t act now.”

Jim Cramer breaks down the two broad camps emerging as the Fed battles inflation

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Business

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus. The agency said the risk […]

Read More
These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More